26 August 2025
Find out how GLP-1 drugs like Ozempic and Wegovy can lower cancer risk while aiding in weight loss and diabetes control.
22 August 2025
Novo Nordisk implements a hiring freeze as layoffs approach after Wegovy's success. Discover the impact on the pharmaceutical industry.
12 August 2025
Explore the Ozempic Paradox: discover how weight-loss drugs impact overall healthcare costs despite health improvements.
29 June 2025
Understand the significance of Ozempic and Mounjaro in the evolving landscape of diabetes care and weight management in South Africa.
28 October 2024
Healthcare costs for US obesity patients rise with GLP-1 drugs despite their weight-loss benefits.
24 October 2024
Novo Nordisk's share price dropped 19% amidst growing competition from Eli Lilly in the diabetes and weight-loss drug market.
12 July 2024
Only 25% of US patients prescribed Wegovy or Ozempic for weight loss continued usage after two years, raising concerns about long-term adherence.